Methods patient population
Review of the records of Beijing Tiantan Hospital for the period from 2003 to 2013 identified 43 patients who had undergone resection of intracranial tumors that were pathologically confirmed to be subependymomas.
record of clinical and radiological Material
The clinical data and operation records of 43 cases with subependymoma were retrospectively reviewed. The recorded information included patient age, sex, initial manifestation, duration of symptoms or signs, preoperative diagnosis, tumor size, location, CT and MRI features, extent of resection, and surgical outcome. Tumor size was recorded according to the measurement of the maximum diameter on MR images. The extent of resection was recorded as gross total, subtotal, or partial according to the operation record and postoperative MR images. Hydrocephalus was defined as abnormal accumulation of cerebrospinal fluid in the ventricles.
pathological examination
Fresh paraffin-embedded tumor tissue was cut into 5-mm sections and stained with hematoxylin and eosin. Immunohistochemical staining was used for differential diagnoses. The microscopic pathologies of 43 cases were reviewed by 2 independent neuropathologists according to the WHO grading system. 10 Immunohistochemical staining was assessed using a semiquantitative scoring system. The expression levels were based on the percentage of immunopositive cells (negative, < 25% of tumor cells; positive, ≥ 25% of tumor cells).
long-term Follow-up
Among 43 patients with subependymoma, 35 were followed up after surgery. Postoperative complications and progression-free and overall survival were recorded. Progression of subependymoma was defined according to the radiological findings after tumor removal. Progression-free survival (PFS) was defined as the time between initial surgery and tumor progression on radiology. Overall survival (OS) was defined as the time between initial surgery and death.
statistical analysis
To select parameters associated with longer PFS and OS, the log-rank test and Cox regression model were used. The chi-square test was used for the comparison of adult and childhood subependymomas. The statistical software SPSS 13.0 (SPSS for Windows, version 13.0, SPSS Inc.) was used. Probability values were obtained from 2-sided tests, with statistical significance defined as p < 0.05.
results

Frequency and clinical Features of intracranial subependymomas
Forty-three cases of pathologically confirmed intracranial subependymoma were identified among the approximately 60,000 cases of surgically intracranial tumors that were treated in Beijing Tiantan Hospital during the study period. The frequency of intracranial subependymoma was thus approximately 0.07%.
Clinical data are summarized in Tables 1 and 2 . The age at onset of symptoms or signs in the 43 patients ranged from 2 to 68 years; the mean age was 33.1 ± 18.9 years (all means are expressed ± SD). These patients included 22 males and 21 females. The time from onset of symptoms or signs to admission ranged from 10 days to 20 years (median 2 months). The initial manifestations of the tumor were headache or intracranial hypertension in 29 patients, dizziness in 10, limb weakness in 5, epilepsy in 4, memory loss in 4, ataxia in 2, tremor in 2, blurred vision in 1, and an enlarged head in 1; in 3 cases, the tumors were incidental findings.
All 43 intracranial subependymomas were primary. In 34 cases (79.1%), the tumors were misdiagnosed preoperatively; 14 tumors (32.6%) were misdiagnosed as gliomas, 9 (20.9%) as central neurocytomas, 8 (18.6%) with ependymomas, 1 (2.3%) as medulloblastoma, 1 (2.3%) as meningioma, and 1 (2.3%) as cavernous an gioma.
Nine patients received postoperative radiotherapy, and 1 patient received postoperative chemotherapy after tumor recurrence.
radiological Features of intracranial subependymomas
The radiological data are summarized in Table 3 . The lesion was located near the Monro foramen in 21 cases, in the fourth ventricle in 7 cases, in the occipital horn of the lateral ventricle in 6 cases, in both the region of the Monro foramen and the 3rd ventricle in 3 cases, in the temporal horn of the lateral ventricle in 1 case, in the fourth ventricle and the pons in 1 case, in the CPA in 1 case, in the frontal lobe in 1 case, in the parietal lobe in 1 case, and in the thalamus, midbrain, and temporal lobe in 1 case.
The tumor was located on the left side in 19 cases and on the right side in 13 cases; it was bilateral in 11 cases.
Multiple lesions were revealed in only 1 case, while single lesions were observed in 42 cases. Regarding tumor shape, 39 tumors were spherical, and 4 were irregular.
The maximum diameters of the lesions ranged from 2.0 to 12.0 cm (mean 4.4 ± 1.7 cm).
CT images were available in 22 cases. The tumors presented as a hypodensity without calcification in 13 of these cases, a hypodensity with calcification in 2 cases, an isodensity without calcification in 4 cases, an isodensity with calcification in 1 cases, and a hyperdensity without calcification in 2 cases.
MR images were available in 38 cases. The tumors presented as hypointense on T1-weighted images and hyperintense on T2-weighted images in 36 cases and as isointense on T1-weighted images and hyperintense on T2-weighted images in 2 cases. The tumors presented with spot-like enhancement in 21 cases, no enhancement in 11 cases, ring-like enhancement in 4 cases, and homogeneous enhancement in 1 case. According to the radiological findings, the tumor border was well defined in 37 cases and poorly defined in 3 cases. Cystic degeneration was found in 35 subependymomas, including 34 cases with microcystic degeneration and 1 case with macrocystic degeneration.
surgical Findings and Outcomes
Data pertaining to surgical findings and outcomes are presented in Table 4 . Intraoperative blood loss in the 43 cases ranged from 50 to 800 ml (median 200 ml). Seventeen tumors were found to originate from the lateral wall of the lateral ventricle, 10 from the septum pellucidum with or without involvement of the lateral wall of the lateral ventricle, 5 from the brainstem, 4 from the thalamus with or without involvement of the caudate nucleus or brainstem, 3 from the cerebellar vermis, 3 from the frontal/parietal/occipital lobe, and 1 from the lateral recess of the fourth ventricle. Gross-total resection was achieved in 30 cases, subtotal resection in 10 cases, and partial resection in 3 cases.
Postoperative complications present at discharge included limb weakness or paralysis in 6 cases (14.0%), hydrocephalus requiring treatment with a ventriculoperitoneal (VP) shunt in 3 cases (7.0%), cough when drinking and/or hoarseness and/or dysphagia in 2 cases (4.7%), ataxia in 1 case (2.3%), aphasia in 1 case (2.3%), memory loss in 1 case (2.3%), and unsmooth speech in 1 case (2.3%). One patient died 8 days after the operation.
At the time of discharge, neurological function showed improvement in 32 cases (74.4%) and worsening in 10 cases (23.3%).
long-term Follow-up
Thirty-five patients with intracranial subependymoma were followed up for 3.0-120.0 months after surgery (median 31.5 months).
At the last follow-up, 3 patients had experienced tumor progression, and the median PFS was not yet available. The 1-, 5-, and 10-year PFS rates were 97.0%, 86.2%, and 86.2%, respectively. One patient died of recurrence. The median OS was also unavailable. The 1-, 5-, and 10-year survival rates were 100.0%, 92.9%, and 92.9%, respectively. Kaplan-Meier plots of PFS and OS are shown in Fig. 1 .
pathological Features of intracranial subependymomas
The pathological data are summarized in Table 5 . Among 43 cases of intracranial subependymoma, 34 cases were pathologically confirmed as pure subependymoma (WHO Grade I), 8 cases as subependymoma with mixed ependymoma (WHO Grade II), and 1 as subependymoma with mixed astrocytoma (WHO Grade II).
Immunostaining was positive for GFAP in 15 (88.2%) of 17 cases, for SYN in 3 (30.0%) of 10 cases, for vimentin in 5 (83.3%) of 6 cases, for EMA in 0 (0.0%) of 6 cases, for MBP in 1 (25.0%) of 4 cases, for S100 in 3 (75.0%) of 4 cases, for oligo2 in 3 (75.0%) of 4 cases, for NF in 0 (0.0%) of 3 cases, and for nestin in 2 (100.0%) of 2 cases. FISH was performed in 5 cases, and none harbored 1p/19q codeletion.
clinical, radiological, and pathological parameters associated With pFs and Os
Patient age, sex, the presence of single or multiple tumors, tumor size, tumor border, the presence of hydro- cephalus, unilateral or bilateral tumor location, extent of resection, tumor grade, pure or mixed subependymoma, and use of radiotherapy were recorded and analyzed. Parameters significantly associated with longer PFS and OS were identified using log-rank analysis and the Cox regression model (Table 6 ). Univariate analysis revealed that only poorly defined tumor borders were significantly associated with shorter PFS. The association between shorter PFS and younger patient age was almost significant (p = 0.51), and for that reason it was also included in the multivariate analysis. Multivariate analysis confirmed only poorly defined borders as an independent prognostic factor for PFS (RR 18.655, 95% CI 1.141-304.884, p = 0.040). No factor was revealed to be an independent predictor of OS.
comparison of cases in children versus patients 14 years or Older
Stratification of the cases by patient age (< 14 years vs ≥ 14 years) showed many differences (Table 7) . Most (96.8%) of the tumors in the patients 14 years or older were located in the supratentorial area, whereas most (66.7%) of those in patients younger than 14 years were located in the infratentorial area (p < 0.001). In the older patient group, most subependymomas (87.1%) were unilateral, whereas most in the younger patient group (58.3%) were bilateral (p = 0.008). Gross-total resection was achieved in 80.6% of patients in the older group and 41.7% of patients in the younger group (p = 0.033). Pathologically, 87.1% of the tumors in patients 14 years of age or older were pure subependymomas, compared with 58.3% in younger patients; the difference was marginally significant (p = 0.097). Moreover, the PFS for older patients was longer than that for those under 14 years (p = 0.051).
illustrative cases case 21
A 33-year-old woman was admitted to our hospital with a radiological diagnosis of subependymoma in the left lateral and third ventricles. She complained of inter- mittent headache for 1 year. Neurological examination revealed no positive signs. The lesion showed a hypodensity adjacent to the Monro foramen on CT ( Fig. 2A and B) and long T1 and long T2 signals with microcystic degeneration and without enhancement on MR images (Fig.  2C-H) . The patient underwent a left frontal transcallosal approach, and gross-total resection of the tumor was achieved ( Fig. 2I-K) . During the operation, the tumor was found to be a gray-white mass in the left lateral and third ventricles. Postoperative pathological examination confirmed the diagnosis of subependymoma (Fig. 2O) .
The patient was discharged 9 days after surgery without any neurological deterioration. She was followed up for 3 years, and no recurrence was found (Fig. 2L-N) .
case 36
A 3-year-old child was admitted to our hospital with a radiological diagnosis of a mass occupying the fourth ventricle and secondary hydrocephalus. He was reported to have been suffering from nausea for 1.5 months and sleepiness for 1 month. Neurological examination revealed papillary edema. CT revealed a hyperdensity in the fourth ventricle (Fig. 3A) . MR images revealed a lesion with long T1 and long T2 signals as well as spot-like enhancement (Fig. 3B-G) . A VP shunt was placed, and 7 days later, surgery was performed via a posterior median approach with the intention of total tumor removal (Fig. 3H-J) . During the operation, the tumor was found to be a gray-red soft mass with well-defined borders. Postoperative pathology revealed the diagnosis of a subependymoma with increased cellularity (WHO Grade I and II) (Fig. 3K) . The patient was discharged 8 days after surgery without any other treatment. Seven months later, the patient was readmitted to our hospital with recurrent headache. Radiological examination revealed a recurrent mass in the fourth ventricle (Fig. 4A-F) . A second operation was performed, and grosstotal resection of the recurrent tumor was achieved (Fig.  4G-K) . Pathological examination resulted in the diagnosis of anaplastic ependymoma (Fig. 4L) . After the operation, the patient underwent radiotherapy and chemotherapy. At the last follow-up 21 months after the primary surgery, the patient was still alive.
Discussion
Intracranial subependymoma is a rare central nervous system tumor that is often misdiagnosed as other diseases. To date, few series of intracranial subependymoma have been reported due to its extremely low incidence. Approximately 60,000 patients with intracranial tumors were surgically treated in our hospital from 2003 to 2013. Among them, 43 patients were found to have pathologically confirmed intracranial subependymoma. To the best of our knowledge, this is the second largest series of intracranial subependymoma from a single neurosurgical center.
lower incidence of intracranial subependymoma and its relationship With ependymomas
The frequency of subependymoma in our hospital was lower than previously reported. A 0.7% incidence of subependymoma was previously reported among 1000 patients with pathologically proven intracranial neoplasms, * Not all tumors were evaluated for these parameters. All data available were analyzed.
and an incidence of 0.4% among 1000 asymptomatic patients has been reported based on autopsy findings. 13 In our center, the estimated incidence of intracranial subependymoma was 0.07%.
Subependymoma appears most likely to arise from subependymal glial precursor cells. 3, 16, 17 Ependymal glial precursor cells are bipotential cells, with the ability to differentiate into either an ependymal cell or an astrocyte. Among 43 subependymoma cases, we found 8 cases with mixed ependymoma, and 1 with mixed astrocytoma. Our finding supports the bipotential hypothesis of ependymal glial precursor cells.
Most subependymomas are benign with a low recurrence rate. However, a few progress as anaplastic ependymoma. Recurrence was seen in 3 of our 43 patients, including 1 with recurrent subependymoma, 1 with anaplastic ependymoma, and 1 with an unavailable pathological diagnosis.
clinical-radiological Differential Diagnoses for intracranial subependymomas
According to the location in the ventricular system and the unique radiological features of intracranial subependymomas, it is not difficult to distinguish them from other tumors. According to our analysis, 39 (90.7%) of 43 cases were located in the ventricular system. Radiologically, most present with hypodensity without calcification on CT and long T1 and T2 signals with no or mild enhancement on MR images. The most characteristic MR feature of intracranial subependymoma is microcysts within the tumors.
Intracranial subependymomas should be differentiated from other intracranial tumors, including ependymomas, medulloblastomas, astrocytomas, central neurocytomas, and meningiomas.
For subependymomas in the area of the Monro foramen, central neurocytoma, glioma, and ependymoma should be included in the differential diagnosis. Neurocytomas present with isodensity or hyperdensity with mild to moderate enhancement on CT scan. 15 Spicules identified at the tumor periphery interfacing with the lateral ventricle walls result in a scalloping appearance, contributing greatly to the specificity and accuracy of the diagnosis.
14 Subependymal giant cell astrocytomas (SGCAs) are a common manifestation of tuberous sclerosis. SGCAs present as areas of hypodensity with calcification on CT. After injection of a contrast agent, they show mild to moderate enhancement. 15 Most ependymomas have a cystic component, and MR contrast enhancement has been reported to show an enhancing nodule within the wall of a cyst, heterogeneous enhancement of cystic and solid lesions, and homogeneous enhancement of solid lesions. 5 For subependymomas in the fourth ventricle, medulloblastoma and low-grade astrocytoma should be included in the differential diagnosis. In adults, most medulloblastomas present as areas of hyperdensity with mild to moderate enhancement on CT and show a low-density area consistent with cystic and necrotic degeneration. In children, the mass has been reported to present as an area of hyperdensity with markedly homogeneous enhancement and to show no cystic or necrotic degeneration.
2 Most low-grade astrocytomas present with long T1 and long T2 signals on MR images and no or mild enhancement, similar to subependymomas. The microcystic signal within the tumor is typically indicative of subependymoma instead of astrocytoma. Subependymomas within the parenchyma are very difficult to differentiate from gliomas. In 3 of our cases, parenchymal subependymoma were initially misdiagnosed as gliomas because there were not enough features for differentiation.
hydrocephalus
Twenty-eight patients experienced hydrocephalus preoperatively, and 3 (10.7%) of them were treated with VP shunting before tumor removal and 1 (3.6%) was treated with VP shunting after tumor removal. All 3 patients who were treated with VP shunts preoperatively were children with a tumor in the fourth ventricle. The patient who had a VP shunt placed postoperatively was an adult with a tumor located near the Monro foramen and in the third ventricle. Preoperative hydrocephalus was resolved by tumor removal in 24 (85.6%) of 28 cases.
Fifteen patients did not present with hydrocephalus preoperatively; 2 of these patients experienced acute hydrocephalus after tumor removal and required VP shunt placement. Both patients were adults with a tumor located near the Monro foramen or in the occipital horn. The frequency of acute postoperative hydrocephalus was 13.3% (2 of 15 cases).
Of the 9 patients with a tumor in the posterior fossa, 7 were complicated by hydrocephalus. In these cases, preoperative VP shunting was recommended to avoid acute cerebellar tonsillar hernia. For the 34 patients with a supratentorial tumor in our series, however, ventriculo-peritoneal shunting was not performed until acute postoperative hydrocephalus occurred.
radiotherapy, recurrence, and survival
Twelve patients were treated with postoperative radio- therapy. Although radiotherapy did not show a significant association with longer survival, it was recommended for patients who had subtotal or partial resection of their tumors and for those with mixed tumor types. Kaplan-Meier plots of PFS and OS are shown in Fig.  1 . Subependymoma is a benign tumor, and long-term survival can be expected of these patients.
comparison of cases in children versus patients 14 years or Older
There were many differences with respect to tumor location, sides, removal degree, pathology, and survival when the patient group was divided based on age (Table  7) . In patients 14 years old or older, these tumors tended to be pure subependymomas located in the unilateral supratentorial area and total removal tends to be easy and PFS tends to be longer. By contrast, in younger patients subependymomas tended to be mixed tumors involving the bilateral infratentorial area, with a lower total removal rate and shorter PFS. All of the above differences suggest that the tumor origins, biological behavior, and prognoses of subependymomas might differ between adults and children.
clinical, radiological, and pathological parameters associated With prognosis
To examine associations with PFS and OS in patients with surgically treated subependymoma, we analyzed clinical, radiological and pathological parameters using the log-rank test and Cox regression model (Table 6) . Poorly defined borders were significantly associated with worse prognosis, and the association between younger age and shorter PFS almost reached significance. Multivariate analysis revealed only poorly defined borders to be an independent prognostic factor for shorter PFS (RR 18.655, 95% CI 1.141-304.884, p = 0.040). No factor was revealed to be an independent predictor of OS. 
study limitations
This was a retrospective review of surgically treated cases of a rare intracranial tumor. This series of cases included a small patient group without any control group. Typical biases exist, and the statistical analysis is limited, given the small number of cases and the retrospective nature of the series. There is concern that correlation may be an artifact of the small group size and lack of controls. Therefore, other series of intracranial subependymomas were analyzed in the discussion, fortifying our observation with similar results.
conclusions
Intracranial subependymoma is a rare benign intracranial tumor with definite radiological features. Long-term survival can be expected, although poorly defined borders are an independent prognostic factor for shorter PFS. The different features between features in cases involving patients older or younger than 14 years suggest that they might have different tumor origins, biological behaviors, and prognoses.
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